Cohere Health COO Duncan Reece: ‘Healthcare is too complex to tackle things in a siloed way’


How a fast-growing healthcare startup is leveraging tech and collaborative partnership to help patients, doctors, and health plans work better together

For a patient to receive many treatments and tests, a doctor first needs to receive approval from a health insurance plan before services can begin. Traditionally, the ‘prior authorization process’ involves wading through red tape and old school systems, which can delay much-needed treatments.

Founded in 2019, Cohere Health aims to streamline this process and offer a different kind of experience for patients, medical providers, and health plans to ultimately improve the quality and speed of care that patients receive. In the past year, Cohere has grown to more than 400 people and secured a $36 million Series B funding bringing their overall total raise to $56 million.

By combining artificial intelligence and machine learning with evidence-based clinical policy, Cohere’s utilization management collaboration platform supports physicians and health plans to make better care decisions for patients. “Collaboration between these entities is important, it just needs to be less burdensome.” says Duncan, COO and Cofounder.

Published On: April 20th, 2022Categories: News

Share:

About the Author: Cohere Health

Cohere Health is a clinical intelligence company that provides intelligent prior authorization as a springboard to better quality outcomes by aligning physicians and health plans on evidence-based care paths for the patient's entire care journey. Cohere's intelligent prior authorization solutions reduce administrative expenses while improving patient outcomes. The company is a Top 5 LinkedIn™ Startup, winner of the TripleTree iAward, consecutive KLAS Research’s Points of Light recipient, and has been named to both Fierce Healthcare's Fierce 15 and CB Insights' Digital Health 150 lists. Cohere's investors include Deerfield Management, Define Ventures, Flare Capital Partners, Longitude Capital, and Polaris Partners.